Evidence map›Paper›PMID 30517687›Full record

ArticleHuman molecular genetics2019

TUBA1A mutations identified in lissencephaly patients dominantly disrupt neuronal migration and impair dynein activity.

Jayne Aiken, Jeffrey K Moore, Emily A Bates

Abstract read
In one paragraph

Article in Human molecular genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Understanding the Molecular Basis of Miller-Dieker Syndrome.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Lissencephaly caused by aFrontiers in pediatrics · 2024
    Article
  9. Review
  10. Article
  11. MAPping tubulin mutations.Frontiers in cell and developmental biology · 2023
    Review
  12. Case report: Structural brain abnormalities inFrontiers in pediatrics · 2023
    Article
  13. Selective motor activation in organelle transport along axons.Nature reviews. Molecular cell biology · 2022
    Review
  14. eLife · 2022
    Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jayne AikenDepartment of Cell and Developmental Biology.
Jeffrey K MooreDepartment of Cell and Developmental Biology.
Emily A BatesDepartment of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
University of Colorado Denver · US

Funding

Regulation of Microtubule Function by Tubulin Carboxy-terminal TailsR01GM112893 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI MOORE, JEFFREY KYLE · 2015 to 2019
$1.5M
NIGMS NIH HHS R01 GM112893
6 · The paper itself

Abstract

The microtubule cytoskeleton supports diverse cellular morphogenesis and migration processes during brain development. Mutations in tubulin genes are associated with severe human brain malformations known as 'tubulinopathies'; however, it is not understood how molecular-level changes in microtubule subunits lead to brain malformations. In this study, we demonstrate that missense mutations affecting arginine at position 402 (R402) of TUBA1A α-tubulin selectively impair dynein motor activity and severely and dominantly disrupt cortical neuronal migration. TUBA1A is the most commonly affected tubulin gene in tubulinopathy patients, and mutations altering R402 account for 30% of all reported TUBA1A mutations. We show for the first time that ectopic expression of TUBA1A-R402C and TUBA1A-R402H patient alleles is sufficient to dominantly disrupt cortical neuronal migration in the developing mouse brain, strongly supporting a causal role in the pathology of brain malformation. To isolate the precise molecular impact of R402 mutations, we generated analogous R402C and R402H mutations in budding yeast α-tubulin, which exhibit a simplified microtubule cytoskeleton. We find that R402 mutant tubulins assemble into microtubules that support normal kinesin motor activity but fail to support the activity of dynein motors. Importantly, the level of dynein impairment scales with the expression level of the mutant in the cell, suggesting a 'poisoning' mechanism in which R402 mutant α-tubulin acts dominantly by populating microtubules with defective binding sites for dynein. Based on our results, we propose a new model for the molecular pathology of tubulinopathies that may also extend to other tubulin-related neuropathies.

Indexed as

AnimalsBrainCell MovementDyneinsLissencephalyMiceMice, Inbred C57BLMicrotubulesMutationMutation, MissenseNeurogenesisNeuronsPrimary Cell CultureRatsRats, Sprague-DawleyTubulinDyneinsTUBA1A protein, humanTuba1a protein, mouseTubulin

Identifiers

PMID30517687
PMCPMC6452179
OpenAlexW2951306127

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.